Guangzhi Wu
-
- MicroRNA in disease regulation 3
-
- Peripheral Nerve Disorders 4
-
- Glycosylation and Glycoproteins Research 3
-
- Orthopedic Surgery and Rehabilitation 8
- Nerve Injury and Rehabilitation 3
-
- Nerve injury and regeneration 4
- Hereditary Neurological Disorders 2
-
- Pain Mechanisms and Treatments 3
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Guangzhi Wu
28 papers receiving 480 citations
Peers
Comparison fields: 5 of 104
- Cancer Research 91
- Radiology, Nuclear Medicine and Imaging 103
- Molecular Biology 209
- Surgery 131
- Cellular and Molecular Neuroscience 48
Countries citing papers authored by Guangzhi Wu
This map shows the geographic impact of Guangzhi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangzhi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangzhi Wu more than expected).
Fields of papers citing papers by Guangzhi Wu
This network shows the impact of papers produced by Guangzhi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangzhi Wu. The network helps show where Guangzhi Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangzhi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2023 | 18 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 94 | |
| 10 | 2020 | 30 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 3 | |
| 14 | miR-182 promotes cell proliferation and invasion by inhibiting APC in melanoma. | 2018 | 9 |
| 15 | 2017 | 2 | |
| 16 | 2014 | 24 | |
| 17 | 2013 | 17 | |
| 18 | 2010 | 11 | |
| 19 | 2008 | 57 | |
| 20 | 1997 | 12 |
About Guangzhi Wu
Guangzhi Wu is a scholar working on Cancer Research, Developmental Neuroscience and Pharmacology, having authored 30 papers that have together received 492 indexed citations. Recurring topics across this work include Orthopedic Surgery and Rehabilitation (8 papers), Peripheral Nerve Disorders (4 papers), Nerve injury and regeneration (4 papers), Glycosylation and Glycoproteins Research (3 papers), MicroRNA in disease regulation (3 papers), Pain Mechanisms and Treatments (3 papers), Nerve Injury and Rehabilitation (3 papers) and Hereditary Neurological Disorders (2 papers). The work is most often cited by research in Cancer Research (91 citations), Radiology, Nuclear Medicine and Imaging (103 citations) and Molecular Biology (209 citations). Guangzhi Wu has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Shusen Cui, Minglei Zhang, Yueying Li, Wenqi Luo, Li Zeng, Xuyang Li, Wei Yu, Ruofeng Yin, Yan Wu and Yew Mun Lee. Their work appears in journals such as PLoS ONE, FEBS Letters and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.